1.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

2.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

3.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

4.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

5.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

6.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

7.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

8.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

9.

Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium

1.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

2.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

3.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

4.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

5.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

6.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

7.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

8.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

9.

Genetic Structure associated with blaOXA-18 Gene, Encoding a Clavulanic-Acid Inhibited Extended-Spectrum Oxacillinase.

1.

Plasmid-Encoded Carbapenem-Hydrolyzing β-Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium

2.

Plasmid-Encoded Carbapenem-Hydrolyzing β-Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium

3.

Plasmid-Encoded Carbapenem-Hydrolyzing β-Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium

4.

Plasmid-Encoded Carbapenem-Hydrolyzing β-Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium

1.

Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals

2.

Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals

3.

Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals

4.

Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals

5.

Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals

6.

Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals

7.

Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals

8.

Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals

9.

Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals

1.

Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum {beta}-lactamase associated with the ST131 Escherichia coli clone in Belgium

2.

Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum {beta}-lactamase associated with the ST131 Escherichia coli clone in Belgium

3.

Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum {beta}-lactamase associated with the ST131 Escherichia coli clone in Belgium

4.

Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum {beta}-lactamase associated with the ST131 Escherichia coli clone in Belgium

5.

Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum {beta}-lactamase associated with the ST131 Escherichia coli clone in Belgium

6.

Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum {beta}-lactamase associated with the ST131 Escherichia coli clone in Belgium

7.

Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum {beta}-lactamase associated with the ST131 Escherichia coli clone in Belgium

8.

Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum {beta}-lactamase associated with the ST131 Escherichia coli clone in Belgium

9.

Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum {beta}-lactamase associated with the ST131 Escherichia coli clone in Belgium

1.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

2.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

3.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

4.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

5.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

6.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

7.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

8.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

9.

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

1.

Carbapenem-Resistant Acinetobacter baumannii Isolates Expressing the bla OXA-23 Gene Associated with IS Aba4 in Belgium

2.

Carbapenem-Resistant Acinetobacter baumannii Isolates Expressing the bla OXA-23 Gene Associated with IS Aba4 in Belgium

3.

Carbapenem-Resistant Acinetobacter baumannii Isolates Expressing the bla OXA-23 Gene Associated with IS Aba4 in Belgium

4.

Carbapenem-Resistant Acinetobacter baumannii Isolates Expressing the bla OXA-23 Gene Associated with IS Aba4 in Belgium

1.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

2.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

3.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

4.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

5.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

6.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

7.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

8.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

9.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium

1.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

2.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

3.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

4.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

5.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

6.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

7.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

8.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

9.

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.

1.

Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in...

2.

Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in...

3.

Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in...

4.

Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in...

5.

Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in...

6.

Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in...

7.

Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in...

8.

Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in...

9.

Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in...